摘要
外泌体是一种由人体细胞分泌的具有双层膜结构的囊性小泡,是胞外囊泡中的一种类型。研究显示,外泌体通过多种途径参与细胞间的信息传导,在膀胱癌的发生、发展和凋亡过程中发挥着重要作用。同时,外泌体的膜结构可以保护其内容物不被人体酶类物质所分解,因此可以作为载体携带相关治疗因子进入膀胱癌细胞。外泌体在膀胱癌的诊治过程中展现出了良好的应用价值,但同时也面临着一些技术挑战,现对上述问题进行文献综述,希望能为膀胱癌的诊疗提供参考。
引文
[1] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[2] Chang SS, Boorjian SA, Chou R, et al. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline[J]. J Urol, 2016, 196(4): 1021-1029.
[3] Akers JC, Gonda D, Kim R, et al. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies[J]. J Neurooncol, 2013, 113(1): 1-11.
[4] Taylor DD, Doellgast GJ. Quantitation of peroxidase-antibody binding to membrane fragments using column chromatography[J]. Anal Biochem, 1979, 98(1): 53-59.
[5] Kosaka N, Yoshioka Y, Hagiwara K, et al. Trash or Treasure: extracellular microRNAs and cell-to-cell communication[J]. Front Genet, 2013, 4: 173.
[6] Naito Y, Yoshioka Y, Yamamoto Y, et al. How cancer cells dictate their microenvironment: present roles of extracellular vesicles[J]. Cell Mol Life Sci, 2017, 74(4): 697-713.
[7] Urbanelli L, Magini A, Buratta S, et al. Signaling pathways in exosomes biogenesis, secretion and fate[J]. Genes (Basel), 2013, 4(2): 152-170.
[8] Chivet M, Javalet C, Hemming F, et al. Exosomes as a novel way of interneuronal communication[J].Biochem Soc Trans,2013,41(1):241-244.
[9] Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review[J]. Cancer Metastasis Rev, 2013, 32(3-4): 623-642.
[10] Kalluri R. The biology and function of exosomes in cancer[J]. J Clin Invest, 2016, 126(4): 1208-1215.
[11] Beckham CJ, Olsen J, Yin PN, et al. Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression[J]. J Urol, 2014, 192(2): 583-592.
[12] Ringuette Goulet C, Bernard G, Tremblay S, et al. Exosomes Induce Fibroblast Differentiation into Cancer-Associated Fibroblasts through TGFbeta Signaling[J]. Mol Cancer Res, 2018, 16(7): 1196-1204.
[13] Franzen CA, Blackwell RH, Todorovic V, et al. Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes[J]. Oncogenesis, 2015, 4: 163.
[14] Yang L, Wu XH, Wang D, et al. Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro[J]. Mol Med Rep, 2013, 8(4): 1272-8.
[15] Lee J, Mckinney KQ, Pavlopoulos AJ, et al. Altered Proteome of Extracellular Vesicles Derived from Bladder Cancer Patients Urine[J]. Mol Cells, 2018, 41(3): 179-187.
[16] Suzuki Y, Sutoh M, Hatakeyama S, et al. MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis[J]. Int J Oncol, 2012, 40(6): 1831-1838.
[17] Nielsen TO, Borre M, Nexo E, et al. Co-expression of HER3 and MUC1 is associated with a favourable prognosis in patients with bladder cancer[J]. BJU Int, 2015, 115(1): 163-165.
[18] Chen C L, Lai YF, Tang P, et al. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients[J]. J Proteome Res, 2012, 11(12): 5611-29.
[19] Perez A, Loizaga A, Arceo R, et al. A Pilot Study on the Potential of RNA-Associated to Urinary Vesicles as a Suitable Non-Invasive Source for Diagnostic Purposes in Bladder Cancer[J]. Cancers (Basel), 2014, 6(1): 179-192.
[20] Matsuzaki K, Fujita K, Jingushi K, et al. MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma[J]. Oncotarget, 2017, 8(15): 24668-24678.
[21] Zheng R, Du M, Wang X, et al. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression[J]. Mol Cancer, 2018, 17(1): 143.
[22] Nishida-Aoki N, Tominaga N, Takeshita F, et al. Disruption of Circulating Extracellular Vesicles as a Novel Therapeutic Strategy against Cancer Metastasis[J]. Mol Ther, 2017, 25(1): 181-191.
[23] Kosaka N, Iguchi H, Hagiwara K, et al. Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis[J]. J Biol Chem, 2013, 288(15): 10849-10859.
[24] Franzen CA, Simms PE, Van Huis AF, et al. Characterization of uptake and internalization of exosomes by bladder cancer cells[J]. Biomed Res Int, 2014: 619829.
[25] Shtam TA, Kovalev RA, Varfolomeeva EY, et al. Exosomes are natural carriers of exogenous siRNA to human cells in vitro[J]. Cell Commun Signal, 2013, 11: 88.
[26] Zhuang X, Xiang X, Grizzle W, et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain[J]. Mol Ther, 2011, 19(10): 1769-1679.
[27] Greco KA, Franzen CA, Foreman KE, et al. PLK-1 Silencing in Bladder Cancer by siRNA Delivered With Exosomes[J]. Urology, 2016, 91: 241.
[28] Liga A, Vliegenthart AD, Oosthuyzen W, et al. Exosome isolation: a microfluidic road-map[J]. Lab Chip, 2015, 15(11): 2388-2394.
[29] Liu C, Guo J, Tian F, et al. Field-Free Isolation of Exosomes from Extracellular Vesicles by Microfluidic Viscoelastic Flows[J], 2017, 11(7): 6968-6976.
[30] Tang KW, Toh QC, Teo BW. Normalisation of urinary biomarkers to creatinine for clinical practice and research--when and why[J]. Singapore Med J, 2015, 56(1): 7-10.
[31] Prunotto M, Farina A, Lane L, et al. Proteomic analysis of podocyte exosome-enriched fraction from normal human urine[J]. J Proteomics, 2013, 82: 193-229.
